Rubedo Life Sciences
PrivateLast Round
Series A
Apr 22, 2024
Total Funding Raised
$53.45M
Company Overview
Rubedo Life Sciences is a biopharmaceutical company that develops therapies for chronic age-related diseases by targeting senescent cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rubedo Life Sciences Comparables
Compare Rubedo Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciduous Therapeutics | 89% | |
| Cleara Biotech | 84% | |
| StarkAge Therapeutics | 82% | |
Rubedo Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 22, 2024 | ||||
| Grant | Feb 6, 2023 | ||||
| Seed | Dec 3, 2020 |
Key People
Founding team and executive leadership
Rubedo Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed, Series A |
| Khosla Ventures | Seed, Series A |
| age1 | Seed |
| Hevolution Foundation | Series A |
| LongeVC | Series A |
| Longevity Fund | Seed |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2025
First patient dosed in Phase 1 trial for RLS-1496.
- Jan 1, 2025
Presented at the 12th Annual Dermatology Summit.
Rubedo Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rubedo Life Sciences's valuation, stock price, and market status.